Clearance Summary
MLL (KMT2A) Breakapart FISH Probe Kit; AML1 (RUNX1) Breakapart FISH Probe Kit, P53 (TP53) Deletion FISH Probe Kit; EVI1 (MECOM) Breakapart FISH Probe Kit, Del(20q) Deletion FISH Probe Kit; AML1/ETO (RUNX1/RUNXIT1)) Translocation, Dual Fusi, CBFB (CBFB) /MYH11 Translocation, Dual Fusion FISH Probe Kit,Del(5q)Deletion FISH Probe Kit; Del(7q)Deletion FISH Probe Kit received FDA 510(k) clearance under submission number DEN170070, sponsored by Cytocell, Ltd.. The device was reviewed via the Direct premarket notification pathway and assigned to the Medical Genetics review panel. The statutory decision date of record is 2018-12-21.
- Submission: DEN170070
- Applicant / Sponsor: Cytocell, Ltd.
- Clearance pathway: Direct
- Review panel: Medical Genetics
- Device class: Class II
- Regulation citation: 21 CFR 864.1880
- Decision date: 2018-12-21
Classification & Regulation
This clearance is catalogued under FDA product code QDI and 21 CFR 864.1880, within the Medical Genetics review panel as a Class II device.